In Reply-The Different Effects of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers on Mortality

被引：1

作者：

Bangalore, Sripal ^{[1
]}

Fakheri, Robert ^{[1
]}

Toklu, Bora ^{[2
]}

Messerli, Franz H. ^{[3
,4
]}

机构：

[1] NYU, Sch Med, New York, NY 10012 USA

[2] Mt Sinai Beth Israel Med Ctr, New York, NY USA

[3] Univ Hosp, Bern, Switzerland

[4] Icahn Sch Med Mt Sinai, New York, NY 10029 USA

来源：

MAYO CLINIC PROCEEDINGS | 2016年 / 91卷 / 07期

关键词：

PLACEBO-CONTROLLED TRIAL; TYPE-2; DIABETES-MELLITUS; NORMAL BLOOD-PRESSURE; CARDIOVASCULAR EVENTS; HYPERTENSIVE PATIENTS; DOUBLE-BLIND; CORONARY; RAMIPRIL; OUTCOMES; PREVENTION;

D O I：

10.1016/j.mayocp.2016.04.020

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：972 / 975

页数：9

共 50 条

[1] Effects of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on peritoneal transport Reply
Nessim, Sharon J.
Perl, Jeffrey
Bargman, Joanne M.
[J]. KIDNEY INTERNATIONAL, 2011, 79 (01) : 137 - 137
[2] Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in atherosclerosis
Lonn E.
[J]. Current Atherosclerosis Reports, 2002, 4 (5) : 363 - 372
[3] In reply - Angiotensin-Converting Enzyme 2 and the Resolution of Inflammation: In Support of Continuation of Prescribed Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers
Sanchis-Gomar, Fabian
Lavie, Carl J.
Perez-Quilis, Carme
Henry, Brandon M.
Lippi, Giuseppe
[J]. MAYO CLINIC PROCEEDINGS, 2020, 95 (07) : 1553 - 1556
[4] Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Myocardial Infarction
Kostis, John B.
[J]. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS, 2019, 24 (04) : 397 - 397
[5] Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers for the Prevention of Migraines
Gales, Barry J.
Bailey, Emilee K.
Reed, Ashley N.
Gales, Mark A.
[J]. ANNALS OF PHARMACOTHERAPY, 2010, 44 (02) : 360 - 366
[6] Are angiotensin-converting enzyme inhibitors and angiotensin 2 receptor blockers teratogenic?
Morton, A. P.
[J]. DIABETIC MEDICINE, 2013, 30 (10) : 1263 - 1264
[7] Angiotensin-Converting Enzyme Inhibitors vs. Angiotensin Receptor Blockers
Tazkarji, Bachir
Ganeshamoorthy, Ambika
Auten, Beth
[J]. AMERICAN FAMILY PHYSICIAN, 2015, 91 (03) : 193 - 194
[8] Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for IgA nephropathy
Dillon, JJ
[J]. SEMINARS IN NEPHROLOGY, 2004, 24 (03) : 218 - 224
[9] Angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers and coronavirus
Verdecchia, Paolo
Angeli, Fabio
Reboldi, Gianpaolo
[J]. JOURNAL OF HYPERTENSION, 2020, 38 (06) : 1190 - 1191
[10] Angioedema Related to Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers
Nguyen, Timothy
[J]. JNP-JOURNAL FOR NURSE PRACTITIONERS, 2018, 14 (09): : 690 - 691

← 1 2 3 4 5 →